Beckley Foundation

The scarcity of the Incilius Alvarius in the wild brought preoccupation regarding the future of the toads, consequently the future of 5-MeO-DMT.
In a conversation with the founder of Egret Bio, Phillipe Henry, and the founder of Lighthouse Genomics Timothy Harvey we were able to understand more about their project Alvarius Research. A project focused on conserving, decoding and editing the genome of the species as well as granting us the biosynthetic reproduction of toad cells.